FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced results from a new study presented at the ...

Please provide your email address to receive an email when new articles are posted on . In a study, the Tecnis Eyhance toric II IOL had good rotational stability over 3 months, significant reduction ...

"Cataract surgeons naturally want to offer patients a little more — without trade-offs," said Terry Kim, M.D., Chief Medical Officer at Alcon. "Surgeons told us they were looking for an enhanced ...